Stock screenerAll disclosures →
EDGAR →
ARGX
Conviction 72HealthcareScan · Tue, Sep 8, 2026ARGX$1,007.32-2.50%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 250.94K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price1,007.32
Change-2.50%
Gap-2.66%
Rel volume0.66×
Avg volume281.5K
Avg $ vol279.67M
SMA 20995.49
SMA 50927.81
SMA 200845.06
Price vs 50+8.57%
Price vs 200+19.20%
MA stackbullish
50/200 cross—
Supertrendup · 967.06
RSI (14)55
MACD hist-2.61
MACD crossbear · 0d
Stoch %K / %D13 / 52
ADX (14)27
+DI / −DI32 / 27
RSI divergence—
MACD divergence—
ATR %+3.11%
ADR %2.61%
52w high1,058.90
52w low663.93
From 52w high-4.87%
Above 52w low+51.72%
New 52w highNo
SqueezeOff
Bollinger width27.81%
%B0.54
Donchian pos72.20%
Donchian high1,072.75
Donchian low837.42
AVWAP (52w high)1,041.26
vs AVWAP high-3.26%
AVWAP (52w low)854.78
vs AVWAP low+17.84%
OBV trendUp
Chaikin MF (20)0.12
Today vs 20d0.66×
Avg vol (14d)250.94K
Avg vol (20d)281.5K
Avg $ vol (20d)279.67M
Market cap62.34B
RS 3m (vs SPY)+11.49%
RS 6m (vs SPY)+29.39%
RS line new highNo
Trend template6/8
Technical rank83.2
1 week-2.36%
1 month+16.45%
3 months+14.16%
6 months+36.05%
1 year+34.17%
YTD+19.92%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target1,180.25
Target upside17.17%
Analyst ratingBuy
Institutional49.63%
Ent. value62.34B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out62.19M
Employees1.86K
ListedThu, May 18, 2017
Free float1.56B
Float %100.0%
Short interest1.2M
Days to cover4.3d
Short volume56.8%
Squeeze score33 / 100
Next earnings—
EPS forecast—
Last EPS vs est$7.32 vs $6.13
Last surprise+19.4% beat
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank83.2 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1,067.16
Support831.93
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in ARGX · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $1K–$15K | 2026-03-30 | 2026-07-21 |
Insider activity
SEC Form 4 transactions in ARGX
No recent insider (Form 4) filings in ARGX. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in ARGX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.